# Janssen-Ortho Inc., Canada clinical trials: 22 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with Janssen-Ortho Inc., Canada as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Janssen-Ortho Inc., Canada: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/janssen-ortho-inc-canada

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| December 2, 2011 | NCT01484301 | Impact of Tolerability Issues on Chronic Pain | Janssen-Ortho Inc., Canada | Observational | Completed | Pain | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01484301) |
| August 29, 2011 | NCT01424930 | A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to... | Janssen-Ortho Inc., Canada | Phase 2 | Completed | Prostate Neoplasms, Prostate Cancer | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01424930) |
| May 7, 2010 | NCT01118702 | A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers | Janssen-Ortho Inc., Canada | Phase 1 | Completed | Pharmacokinetics | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01118702) |
| December 1, 2008 | NCT00799539 | A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously... | Janssen-Ortho Inc., Canada | Not applicable | No longer available | Multiple Myeloma | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00799539) |
| July 21, 2008 | NCT00718640 | An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function | Janssen-Ortho Inc., Canada | Phase 2 | Terminated | Multiple Myeloma | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00718640) |
| April 4, 2008 | NCT00653016 | An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous... | Janssen-Ortho Inc., Canada | Phase 4 | Completed | Female Contraception | 405 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00653016) |
| November 21, 2007 | NCT00561743 | A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in... | Janssen-Ortho Inc., Canada | Phase 2 | Completed | Multiple Myeloma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00561743) |
| November 5, 2007 | NCT00553449 | Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time... | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Gastroesophageal Reflux, Heartburn | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00553449) |
| September 19, 2006 | NCT00378287 | A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole | Janssen-Ortho Inc., Canada | Phase 1 | Completed | GERD | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00378287) |
| August 15, 2006 | NCT00364455 | Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Prostate, Carcinoma | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00364455) |
| August 15, 2006 | NCT00364260 | A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Anemia, Kidney Failure, Left Ventricular Hypertrophy | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00364260) |
| March 20, 2006 | NCT00304681 | An Effectiveness and Safety Study of CONCERTA\* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder... | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Attention Deficit Hyperactivity Disorder | 147 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00304681) |
| December 26, 2005 | NCT00269971 | A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip... | Janssen-Ortho Inc., Canada | Phase 3 | Withdrawn | Anemia, Blood Transfusion, Orthopedic Surgery | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00269971) |
| December 26, 2005 | NCT00269958 | A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the... | Janssen-Ortho Inc., Canada | Phase 2 | Completed | Anemia | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00269958) |
| December 5, 2005 | NCT00261508 | A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other... | Janssen-Ortho Inc., Canada | Phase 3 | Completed | DCild Development Disorders, Pervasive, Autistic Disorder, Developmental Disabilities, Asperger Syndrome, Rett Syndrome | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00261508) |
| December 5, 2005 | NCT00261469 | An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment... | Janssen-Ortho Inc., Canada | Phase 2 | Completed | Headache | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00261469) |
| November 22, 2005 | NCT00256997 | A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly... | Janssen-Ortho Inc., Canada | Phase 4 | Terminated | Schizophrenia | 167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00256997) |
| October 31, 2005 | NCT00246272 | An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an... | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Schizophrenia | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00246272) |
| October 31, 2005 | NCT00246259 | A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis | Janssen-Ortho Inc., Canada | Phase 4 | Completed | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorders | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00246259) |
| October 31, 2005 | NCT00246246 | A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Bipolar Disorder | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00246246) |
| October 31, 2005 | NCT00246233 | CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder. | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Depressive Disorder, Major | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00246233) |
| October 31, 2005 | NCT00246207 | CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults | Janssen-Ortho Inc., Canada | Phase 3 | Completed | Attention Deficit Disorder With Hyperactivity | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00246207) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 10 |
| Phase 4 | 3 |
| Not applicable | 1 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 18 |
| Terminated | 2 |
| No longer available | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Anemia | 4 |
| Multiple Myeloma | 3 |
| Schizophrenia | 3 |
| Gastroesophageal Reflux | 2 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Heartburn | 1 |
| Renal Insufficiency | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Pain | 1 |
| Chronic Pain | 1 |
| Headache | 1 |
| Migraine Disorders | 1 |
| Depressive Disorder, Major | 1 |
| Autistic Disorder | 1 |
| Developmental Disabilities | 1 |
| Asperger Syndrome | 1 |
| Rett Syndrome | 1 |
| Child Development Disorders, Pervasive | 1 |
| Psychotic Disorders | 1 |
| Bipolar Disorder | 1 |
| Prostatic Neoplasms | 1 |
| Carcinoma | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Hot dog restaurants in the United States](https://specstream.ai/data/businesses/hot-dog-restaurants/united-states)
- [Vehicle shipping companies in the United States](https://specstream.ai/data/businesses/vehicle-shipping-companies/united-states)
- [Glass manufacturers in the United States](https://specstream.ai/data/businesses/glass-manufacturers/united-states)
- [Tiki bars in the United States](https://specstream.ai/data/businesses/tiki-bars/united-states)
- [Fireplace services in the United States](https://specstream.ai/data/businesses/fireplace-services/united-states)
- [Spring suppliers in the United States](https://specstream.ai/data/businesses/spring-suppliers/united-states)
